Literature DB >> 3976379

Effects of electronic fetal monitoring on rates of early neonatal death, low Apgar score, and cesarean section.

S Greenland, J Olsen, P Rachootin, G T Pedersen.   

Abstract

Using data from the University Hospital in Odense, Denmark, we have studied the effects of electronic fetal monitoring on rates of early neonatal death (death of liveborn within first week of life), low five-minute Apgar score (less than 7), and cesarean section. Approximately 22 000 births occurring in 1974 - 82 were studied, of which 13% were electronically monitored. Monitoring was significantly associated with an elevated cesarean rate in low-risk labors and certain high-risk labors, but appeared not to increase the cesarean rate in all high-risk labors. In high-risk labors, monitoring was associated with an approximate 40% reduction in rates of low Apgar score and early neonatal death, but neither reduction was statistically significant. The associations of monitoring with elevated cesarean rate declined significantly over the study period. These results accord closely with studies conducted in the United States, indicating that monitoring is of benefit in high-risk labors, but leads to excessive cesarean deliveries in low-risk labors. Our study additionally indicates that the effect of monitoring on the cesarean rate has been declining over time.

Entities:  

Mesh:

Year:  1985        PMID: 3976379     DOI: 10.3109/00016348509154692

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  2 in total

1.  Periodic health examination, 1989 update: 4. Intrapartum electronic fetal monitoring and prevention of neonatal herpes simplex. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1989-12-15       Impact factor: 8.262

2.  Increased obstetric activity: a new meaning to "induced labour"?

Authors:  S Vallgårda
Journal:  J Epidemiol Community Health       Date:  1989-03       Impact factor: 3.710

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.